AAPS Immunogenicity Risk Assessment and Mitigation Working Group Goals for 2020
Scientific Focus
-
- Webinar
- Ask the Expert Session – 12 pm, April 30th, Thursday "Immunogenicity Risk Assessment Tools and Mitigation"
- Manuscript/White Paper Goal
- Manuscript on survey of risk assessment tools from the Risk Assessment Community (Assay Survey and Harmonization)
- Compendium of manuscripts on how to perform modality based risk assessments
- An inter-community collaboration
- A topical discussion with one other with one other community ;
- TPI community and the Biopharmaceutical Product Attribute and Biological Consequences will work together on this discussion TBD
- A broad progress update at least twice a year
- Progress update to AAPS community in May scheduled online
- October at Pharm Sci 360 as part of community social
- At least one student/post-doc/early career scientist development objective.
- Reach out to student community for a volunteer on monthly calls
- Expand outreach
- European Immunogenicity community and collaborate on proposals for workshops and programming for Pharm Sci 360 for AAPS / EIP assay harmonization workshop proposal
- Initiate new discussion groups
- Novel Modalities Immunogenicity
- CMC CQA issues and Immunogenicity of biologics
- Residual impurities risk assessment and regulatory requirements